We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Laser Light Method Uses AI-Assisted Imaging to Identify Bacteria in Fluids

By LabMedica International staff writers
Posted on 06 Mar 2023

The commonly used traditional culturing techniques often require several hours or even days for completion. More...

Now, a revolutionary approach promises to deliver faster, more precise, and cost-effective microbial assays of almost any fluid one wishes to test for microbes in an instant.

Scientists at Stanford University (Stanford, CA, USA) have created an innovative adaptation of the technology in an old inkjet printer and combined it with AI-assisted imaging to develop a faster, cheaper way to spot bacteria in blood, wastewater, and more. The method involves shining a laser on a drop of blood, mucus, or wastewater, and then using the light reflecting back to positively identify bacteria in the sample. The new test can be carried out within minutes and offers hope for improved and rapid detection of infections, more effective utilization of antibiotics, safer food products, enhanced environmental surveillance, and speedier drug development processes.

The novelty of this discovery lies not in the fact that bacteria possess unique spectral fingerprints, which has been established for years, but rather in how the research team has managed to extract these spectra amidst the blinding array of light emanating from every sample. A single milliliter of blood can contain billions of cells, merely a tiny fraction of which may be microbes. Therefore, the challenge was to identify a way to exclusively distinguish and amplify the light emanating just from the bacteria. The team pursued different scientific approaches, blending a decades-old computing technology - the inkjet printer - with two of the most advanced technologies of our times - artificial intelligence and nanoparticles.

The researchers found a solution to the difficulties of handling biological samples by modifying the printer to use acoustic pulses in order to put samples to paper. This method results in each printed blood dot being just two trillionths of a liter in volume, making them incredibly small - over a billion times smaller than a raindrop. Due to their tiny size, these droplets may contain just a few dozen cells. To enhance the bacteria detection process, the researchers infused the samples with gold nanorods, which act like antennas that draw laser light towards any present bacteria and amplify the signal to 1500 times its original strength. With appropriate isolation and amplification, the bacterial spectra clearly stand out for identification. The researchers also utilized machine learning to analyze the spectra of each printed dot and identify any telltale signatures of bacteria in the sample.

“We can find out not just that bacteria are present, but specifically which bacteria are in the sample – E. coli, Staphylococcus, Streptococcus, Salmonella, anthrax, and more,” said Jennifer Dionne, an associate professor of materials science and engineering and, by courtesy, of radiology at Stanford University. “Every microbe has its own unique optical fingerprint. It’s like the genetic and proteomic code scribbled in light.”

Related Links:
Stanford University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.